An Intermediate Step for the Management of Hypersensitivity to Platinum and Taxane Chemotherapy

Mala Bahl; Terry Dean

doi:10.3747/co.22.2400

You are currently viewing a new version of our website. To view the old version click .

Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Letter

1 June 2015

An Intermediate Step for the Management of Hypersensitivity to Platinum and Taxane Chemotherapy

and

Grand River Regional Cancer Centre, 835 King Street West, Kitchener, ON, Canada

Author to whom correspondence should be addressed.

Curr. Oncol.2015, 22(3), 220-221;https://doi.org/10.3747/co.22.2400

Version Notes

Order Reprints

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The guideline article “Management of hypersensitivity to platinum- and taxane-based chemotherapy: cepo review and clinical recommendations” in this journal for the management of hypersensitivity reactions (HSR) to this group of chemotherapy agents is useful in clinical practice [...]

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Patient with Inoperable Pheochromocytoma

Book Review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty